Adma Biologics Stock Falls Amid Market Uptick What Investors Need to Know

ADMA Stock  USD 21.83  0.01  0.05%   
About 60% of ADMA Biologics' investor base is looking to short. The analysis of the overall investor sentiment regarding ADMA Biologics suggests that many traders are alarmed. The current market sentiment, together with ADMA Biologics' historical and current headlines, can help investors time the market. In addition, many technical investors use ADMA Biologics stock news signals to limit their universe of possible portfolio assets.
  
Adma Biologics concluded the recent trading session at 10.84, signifying a -1.54 percent move from its prior days close.

Read at zacks.com
zacks News
  

ADMA Biologics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards ADMA Biologics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

ADMA Biologics Fundamental Analysis

We analyze ADMA Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ADMA Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ADMA Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Debt To Equity

Debt To Equity Comparative Analysis

ADMA Biologics is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

ADMA Biologics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ADMA Biologics stock to make a market-neutral strategy. Peer analysis of ADMA Biologics could also be used in its relative valuation, which is a method of valuing ADMA Biologics by comparing valuation metrics with similar companies.

Peers

ADMA Biologics Related Equities

FATEFate Therapeutics   18.28   
0%
100.0%
XFORX4 Pharmaceuticals   11.43   
0%
62.0%
CRBUCaribou Biosciences   8.91   
0%
48.0%
MCRBSeres Therapeutics   4.55   
0%
24.0%
SANASana Biotechnology   4.08   
0%
22.0%
IBIOIbio   3.54   
0%
19.0%
TFFPTff Pharmaceuticals   3.33   
0%
18.0%
CDTXCidara Therapeutics   3.11   
0%
17.0%
ETNB89bio   2.70   
0%
14.0%
ANEBAnebulo Pharmaceuticals   2.14   
0%
11.0%
VXRTVaxart   1.67   
0%
9.0%
PLRXPliant Therapeutics   1.42   
0%
7.0%
STOKStoke Therapeutics   1.19   
0%
6.0%
PLXProtalix Biotherapeutics   0.60   
0%
3.0%
AKBAAkebia Ther   0.49   
0%
2.0%
INMBINmune Bio   0.20   
0%
1.0%
BCRXBioCryst Pharmaceuticals   0.13   
0%
1.0%
RCUSArcus Biosciences   0.06   
0%
1.0%
ATRAAtara Biotherapeutics   0.65   
3.0%
0%
ANTXAN2 Therapeutics   1.44   
7.0%
0%
MDGLMadrigal Pharmaceuticals   1.57   
8.0%
0%
ACLXArcellx   2.08   
11.0%
0%
TNXPTonix Pharmaceuticals   5.00   
27.0%
0%

Complementary Tools for ADMA Stock analysis

When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets